These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 30580427)

  • 1. From cfDNA to Sequencing: Workflows and Potentials.
    Tebaldi M; Salvi S
    Methods Mol Biol; 2019; 1909():119-125. PubMed ID: 30580427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of Preanalytic and Analytic Variables for Clinical Next-Generation Sequencing of Circulating Cell-Free Nucleic Acid.
    Mehrotra M; Singh RR; Chen W; Huang RSP; Almohammedsalim AA; Barkoh BA; Simien CM; Hernandez M; Behrens C; Patel KP; Routbort MJ; Broaddus RR; Medeiros LJ; Wistuba II; Kopetz S; Luthra R
    J Mol Diagn; 2017 Jul; 19(4):514-524. PubMed ID: 28506684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of mutational patterns in cell-free DNA of colorectal cancer by custom amplicon sequencing.
    Herrmann S; Zhan T; Betge J; Rauscher B; Belle S; Gutting T; Schulte N; Jesenofsky R; Härtel N; Gaiser T; Hofheinz RD; Ebert MP; Boutros M
    Mol Oncol; 2019 Aug; 13(8):1669-1683. PubMed ID: 31254442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective blinded study of somatic mutation detection in cell-free DNA utilizing a targeted 54-gene next generation sequencing panel in metastatic solid tumor patients.
    Kim ST; Lee WS; Lanman RB; Mortimer S; Zill OA; Kim KM; Jang KT; Kim SH; Park SH; Park JO; Park YS; Lim HY; Eltoukhy H; Kang WK; Lee WY; Kim HC; Park K; Lee J; Talasaz A
    Oncotarget; 2015 Nov; 6(37):40360-9. PubMed ID: 26452027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical analysis of mutant allele frequency level of circulating cell-free DNA and blood cells in healthy individuals.
    Xia L; Li Z; Zhou B; Tian G; Zeng L; Dai H; Li X; Liu C; Lu S; Xu F; Tu X; Deng F; Xie Y; Huang W; He J
    Sci Rep; 2017 Aug; 7(1):7526. PubMed ID: 28790338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic Tumor Mutations Detected by Targeted Next Generation Sequencing in Minute Amounts of Serum-Derived Cell-Free DNA.
    Weerts MJA; van Marion R; Helmijr JCA; Beaufort CM; Krol NMG; Trapman-Jansen AMAC; Dinjens WNM; Sleijfer S; Jansen MPHM; Martens JWM
    Sci Rep; 2017 May; 7(1):2136. PubMed ID: 28522829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance comparison of two next-generation sequencing panels to detect actionable mutations in cell-free DNA in cancer patients.
    Macías M; Cañada-Higueras E; Alegre E; Bielsa A; Gracia J; Patiño-García A; Ferrer-Costa R; Sendino T; Andueza MP; Mateos B; Rodríguez J; Corral J; Gúrpide A; Lopez-Picazo JM; Perez-Gracia JL; Gil-Bazo I; Alkorta-Aranburu G; González Á
    Clin Chem Lab Med; 2020 Jul; 58(8):1341-1348. PubMed ID: 32623849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Optimized Workflow to Evaluate Estrogen Receptor Gene Mutations in Small Amounts of Cell-Free DNA.
    Vitale SR; Sieuwerts AM; Beije N; Kraan J; Angus L; Mostert B; Reijm EA; Van NM; van Marion R; Dirix LY; Hamberg P; de Jongh FE; Jager A; Foekens JA; Vigneri P; Sleijfer S; Jansen MPHM; Martens JWM
    J Mol Diagn; 2019 Jan; 21(1):123-137. PubMed ID: 30296589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of DNA lesions associated with cell-free DNA by targeted deep sequencing.
    Shin SH; Park WY; Park D
    BMC Med Genomics; 2021 Jul; 14(1):192. PubMed ID: 34320984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technical Validation of a Next-Generation Sequencing Assay for Detecting Clinically Relevant Levels of Breast Cancer-Related Single-Nucleotide Variants and Copy Number Variants Using Simulated Cell-Free DNA.
    Yang X; Chu Y; Zhang R; Han Y; Zhang L; Fu Y; Li D; Peng R; Li D; Ding J; Li Z; Zhao M; Zhang K; Lu T; Yi L; Wu Q; Lin G; Xie J; Liu T; Yang L; Yi X; Li J
    J Mol Diagn; 2017 Jul; 19(4):525-536. PubMed ID: 28502728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digital Droplet PCR for Monitoring Tissue-Specific Cell Death Using DNA Methylation Patterns of Circulating Cell-Free DNA.
    Shemer R; Magenheim J; Dor Y
    Curr Protoc Mol Biol; 2019 Jun; 127(1):e90. PubMed ID: 31237424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer.
    Bennett CW; Berchem G; Kim YJ; El-Khoury V
    Oncotarget; 2016 Oct; 7(43):71013-71035. PubMed ID: 27589834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinatory Analysis of Cell-free and Circulating Tumor Cell DNAs Provides More Variants for Cancer Treatment.
    Lee SY; Chae DK; An J; Yoo S; Jung S; Chae CH; Bhak J; Kim BC; Cho DH
    Anticancer Res; 2019 Dec; 39(12):6595-6602. PubMed ID: 31810925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-free DNA next-generation sequencing successfully detects infectious pathogens in pediatric oncology and hematopoietic stem cell transplant patients at risk for invasive fungal disease.
    Armstrong AE; Rossoff J; Hollemon D; Hong DK; Muller WJ; Chaudhury S
    Pediatr Blood Cancer; 2019 Jul; 66(7):e27734. PubMed ID: 30941906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial.
    Jovelet C; Ileana E; Le Deley MC; Motté N; Rosellini S; Romero A; Lefebvre C; Pedrero M; Pata-Merci N; Droin N; Deloger M; Massard C; Hollebecque A; Ferté C; Boichard A; Postel-Vinay S; Ngo-Camus M; De Baere T; Vielh P; Scoazec JY; Vassal G; Eggermont A; André F; Soria JC; Lacroix L
    Clin Cancer Res; 2016 Jun; 22(12):2960-8. PubMed ID: 26758560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrimination of Germline
    Hu Y; Alden RS; Odegaard JI; Fairclough SR; Chen R; Heng J; Feeney N; Nagy RJ; Shah J; Ulrich B; Gutierrez M; Lanman RB; Garber JE; Paweletz CP; Oxnard GR
    Clin Cancer Res; 2017 Dec; 23(23):7351-7359. PubMed ID: 28947568
    [No Abstract]   [Full Text] [Related]  

  • 17. Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients.
    Martignano F; Munagala U; Crucitta S; Mingrino A; Semeraro R; Del Re M; Petrini I; Magi A; Conticello SG
    Mol Cancer; 2021 Feb; 20(1):32. PubMed ID: 33579306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic biases in reference-based plasma cell-free DNA fragmentomic profiling.
    Liu X; Yang M; Hu D; An Y; Wang W; Lin H; Pan Y; Ju J; Sun K
    Cell Rep Methods; 2024 Jun; 4(6):100793. PubMed ID: 38866008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. dPCR Mutational Analyses in Cell-Free DNA: A Comparison with Tissues.
    Takeshita T; Iwase H
    Methods Mol Biol; 2019; 1909():105-118. PubMed ID: 30580426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly sensitive and specific real-time PCR by employing serial invasive reaction as a sequence identifier for quantifying EGFR mutation abundance in cfDNA.
    Xiang Z; Wan R; Zou B; Qi X; Huang Q; Kumar S; Pitman JL; Zhou G; Song Q
    Anal Bioanal Chem; 2018 Oct; 410(26):6751-6759. PubMed ID: 30128808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.